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A REPORT ON PROPANIDID, AN INTRAVENOUS ANAESTHETIC, IN
PORPHYRIA VARIEGATA*
GEOFFREY DEAN, t M.D., ER.C.P., Eastern Cape Provincial Hospital. WITH THE COOPERATION OF THE ANAESTHETIST
OF PORT ELIZABETH
The first account of acute porphyria after taking barbitu-
rates was described in 1906 by Dobrschansky.' Since then
barbiturates, particularly the pentobarbitones, have been
the commonest drug to cause attacks of acute porphyria
in all 3 Mendelian-dominant hepatic porphyrias, inter-
mittent acute porphyria, porphyria variegata and copro-
porphyria. Acute porphyria may result in the paralysis
and death of the patient.
Among the South African White population porphyria
variegata is common.' In the adult who has inherited
porphyria variegata there is usually, but not always, a
high excretion of proto- and coproporphyrin in the stooL'
At the Eastern Cape Provincial Hospital before 1959 we
would diagnose, on average, 12 cases of acute porphyria
each year. Acute attacks of porphyria were so regular an
occurrence and so frequently followed a thiopentone
anaesthetic that it was decided in 1959 to examine the
stools of all patients admitted to hospital in Port Elizabeth
for excess porphyrin before an intravenous thiopentone
anaesthetic was administered. Following the introduction
of routine stool testing, it became possible to estimate the
prevalence of porphyria in the White population of the
Eastern Cape and later in South Africa as a whole. The
prevalence of porphyria variegata in the Eastern Cape is
1 in 250 and for the whole of South Africa it is estimated
to be 1 in 400 of the White population. Over 9,000 of the
White population of South Africa have inherited porphyria
variegata.' It is also fairly common among the Coloured
• people of South Africa. I have attended 54 patients who
have developed acute porphyria after" a thiopentone anaes-
thetic. although thiopentone was not the only barbiturate
used in every case. Thiopentone does not always precipitate
an acute attack of porphyria variegata when the disorder
has been inherited. In children and old people acute
attacks are rare, but in adults between the ages of 16 and
60 years thiopentone will usually precipitate at least a mild
attack of acute porphyria.
The routine screening test of the stool for porphyria
variegata is very simple.' A small fragment of stool, such
as can be obtained, if necessary, on the gloved finger on
rectal examination, is dissolved in a solvent consisting of
equal parts of amyl alcohol, glacial acetic acid and ether;
after the solution has been decanted it is examined in
ultraviolet light.' In adults with porphyria variegata there
is usually a high excretion of porphyrin in the stool and
the decanted solution will show a brilliant pink fluores-
cence in ultraviolet light. CWorophyll will also show a
pink fluorescence, but when N /1 hydrochloric acid is add-
ed to the solution and the mixture is shaken the porphyrin
will settle in the acid solution at the bottom and the
chlorophyll will stay in the ether solution at the top. If
the diagnosis is in doubt, it can then be confirmed by
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examination of the urine for porphyrin and by a quanti-
tative analysis of the stool porphyrin using the method of
Holti and Rimington.' There are other conditions besides
porphyria variegata which can cause an increase in stool
porphyrin, such as. for instance, carcinoma of the
stomach, and therefore not every patient with increased
stool porphyrin has necessarily inherited porphyria
variegata. However, it is usually fairly simple-by repeat-
ing the screening examination, carrying out quantitative
analysis of the stool porphyrin and by obtaining a per-
sonal and family history of a sensitive skin on the back of
the hands or attacks of acute porphyria-to confirm the
diagnosis. Porphobilinogen, which can be detected by the
Watson-Schwartz test using Ehrlich's aldehyde reagent.
will only be positive in porphyria variegata during an
acute attack. The Watson-Schwartz test, therefore, cannot
be used for screening for porphyria variegata in the
quiescent phase. The urine should also be examined for
excess porphyrin.
After the introduction of routine testing for porphyria
variegata before operation in the Eastern Cape, patients
who had positive stools on screening and who might
therefore have been porphyric were given an alternative
anaesthetic to thiopentone, such as gas, oxygen and ether,
although only a proportion of these patients had inherited
porphyria variegata. In the others there was usually only
a slight transient increase in porphyrin or there was pathO-
logy in the gastro-intestinal tract.
Porphyria occurs relatively frequently in South Africa
because a small nucleus of early settlers have become a
people so that over one-third of South Africa's 31- million
White population hold 40 family names which they have
derived from 40 original Free BUllghers.' One of the early
Free Burghers happened by chance to carry the gene for
porphyria variegata. Porphyria variegata in South Africa
has been traced back to either Gerrit the son of Jan, or hi
wife Ariaantje the daughter of Jacob who married at the
Cape in 1688."
Routine testing for porphyria variegata in Port Eliza-
beth and in other Eastern Cape towns greatly reduced the
number of patients who developed acute porphyria each
year, but nevertheless every year 2 or 3 patients are still
seen with a severe attack of acute porphyria, often after
a thiopentone anaesthetic, because for some reason the
routine test had been neglected or occasionally because
the increased porphyrin excretion was so slight that it wa
not considered likely that the patient had porphyria
variegata. Many thousands of thiopentone anaesthetics are
given in South Africa each year and the possibility that
the patient has porphyria variegata has created a most
serious problem for anaesthetists. It is not always easy to
obtain a specimen to carry out a routine test before
operation, and with a large number of patients the
routine testing does create considerable additional effort
for the hospital staff.
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IABLE I. PATlE TS WITH PORPHYRIA VARlEGATA ANAESTHETIZED WITH PROPANIDID
Urine Stool
Case Propanidid







UVL !"g./G !"g./G Family
screen dry wt. dry wt. history Personal histo,¥,
500 Abscess jaw
350 Dilatation cervix
500 Operation on jaw
350 Operation on jaw
350 Dental extractions
400 Draining pilonidal abscess







500 Bartholin cyst removed
350 Curette cervix
Stool porphyrin raised. Confirmed by
Rimington. X-porphyrin 91 /Lg./G.
Acute porphyria 1956, thiopentone.
Sister had acute porphyria after
thiopentone.
Father acute porphyria after thiopen-
tone.
Father died acute porphyria after
thiopentone.
Acute porphyria after thiopentone.
Delay in doing Watson-Schwartz test.
No ill-effects from anaesthetic.
High stool porphyrin 1960.
Previous acute porphyria barbiturates"
Groote Schuur, 1955. Sister acute
porphyria after thiopentone.
Known porphyric.
Skin lesions of porphyria when a young
man.
No ill-effects from repeated propanidid
anaesthetic.
Acute porphyria after barbiturates.
Previous acute porphyria thiopentone
(0) 1961, (b) 1964. Mother had acute
porphyria Groote Schuur. Aunt died
acute porphyria Watford Hospital,
England, 1962.
Acute porphyria 1956 after thiopentone.




(b) One month before propanidid
both after barbiturates.
Mother died acute porphyria after
thiopentone.
Father died acute porphyria after
barbiturates.
Father has had acute porphyria.
Previous acute porphyria after barbitu·
rates.
Sister died acute porphyria after
thiopentone.
Previous acute porphyria after thio-
pentone. Skin lesions as a young
man. Porphyria now quiescenr.
Daughter acute porphyria.
Previous acute porphyria after thio·
pentone. Paralysed 6 months.
Became partly paralysed after pento-





































































































































































































































" 2 weeks later
















































































































































The range of normal for quantitative porphyrin in stool is taken as coproporphyrin 0-36, protoporphyrin 0-113 !"g./G dry weight. A total porphyrin about 80 /Lg./G
is suspicious of porphyna.
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PROPANIDID
In the early 1960s a short-acting non-barbiturate intra-
venous anaesthetic, Fabantol, was introduced (Epontol in
the United Kingdom-:-generic name propanidid). It is a
pale yellowish oil, insoluble in water.
The usual anaesthetic dose of propanidid for adults is be-
tween 5 and 10 mg./kg. of body-weight, given in a 5% solu-
tion. It is given at an injection speed of 1 ml./2 seconds and
produces a rapid, smooth anaesthetic induction, conscious-
ness being lost after 1 arm-brain circulation time. As with
thiopentone, excitatory phenomena are sometimes seen dur-
ing induction when atropine only is used as a premedicant,
but this is very rare when an opiate premedicant is used.
Recovery of consciousness is related to dosage and be-
gins 3 - 6 minutes after a single injection and is usually
complete within 5 or 10 minutes. After induction with
propanidid it is practical to continue the anaesthetic with
gas and oxygen and other anaesthetics. There is a very
rapid recovery time when propanidid is given alone, and
the majority of patients are able to leave hospital within
20 minutes of the anaesthetic. Propanidid is therefore ex-
cellent for minor operations. It is generally well tolerated,
and nausea and vomiting are rare when it is used as the
sole anaesthetic agent"·
Dowdle studied the effects of the drug on the porphyrin
p:oduction of embryo chicks and concluded that the drug
did cause some slight increase in porphyrin production."
The Present Study
Because of the unknown effects of propanidid in
patients with porphyria variegata, it was not possible to
recommend that the drug be tried out in an experimental
form. The anaesthetists in Port Elizabeth and Dr A. C.
Anderson of Bloemfontein took part in this study by in-
forming me when any patient who was suspected to have
porphyria variegata had, at their discretion, been given
propanidid. These patients were usually studied in hospi-
tal after the operation. Their personal and family history
was taken, and they were examined for a sensitive skin on
the back of the hands. Their stools were examined for
excess porphyrin, and when there was any doubt about the
diagnosis a quantitative porphyrin analysis was carried
out by the South African Institute for Medical Research.
Johannesburg. The urine was examined for porphyrin and
porphobilinogen on a number of occasions after the
anaesthetic. After full study, about half of the suspected
patients who had a positive stool test on routine screening
were found to have inherited porphyria variegata.
RESULTS
Thirty-two patients, 9 men and 23 women, with proved
porphyria variegata who had been given 50 propanidid
anaesthetics, have been studied over a period of a year.
Twenty-eight of these patients with porphyria variegata
were given the propanidid anaesthetic in Port Elizabeth
(fable I). The other 4 patients were treated in Bloemfon-
tein. Only one patient, who was almost certainly in an
acute attack at the time of the anaesthetic, had any symp-
toms suggestive of acute porphyria after the propanidid
anaesthetic. They all made uneventful recoveries. In no
patient did the Watson-Schwartz test become positive
when it was previously negative, and in the case of the
4
patient with acute porphyria, where the Watson-Schwartz
test was positive on the day following the anaesthetic, it
became negative after a week. Six of the e patients had
suffe.red from attacks of acute porphyria in the pa t after
a thiopentone anaesthetic, and a further 4 had had acute
porphyria after other barbiturate drugs. Most of these
patient.s had. relatives who had developed acute porphyria
followmg thIOpentone or barbiturate drugs.
One patient (No. 7) was treated by me for an attack of
acute porphyria only 4 weeks before the propanidid
anaesthetic. During the acute attack, which followed
barbiturate sleeping tablets, the Watson-Schwartz test wa
strongly positive. The patient suffered severe abdominal
pain and had attacks of vomiting. Four weeks later, at the
time of the propanidid anaesthetic, the Watson-Schwartz
test had become negative. In spite of the recent acute at-
tack of porphyria the propanidid caused no flare-up of
porphyric symptoms and the Watson-Schwartz test for
porphobilinogen remained negative. Patient No. 8, who
knew she had inherited porphyria, developed abdominal
pain after taking barbiturate sleeping tablets. Her doctor
made a presumptive diagnosis of acute appendicitis and
removed her appendix, using propanidid to induce
anaesthesia. On the following day the Watson-Schwartz
test was strongly positive and for a few days the abdomi-
nal pain persisted. The appendix appeared to be normal.
Over the period of a week the patient made a good re-
covery and the Watson-Schwartz test for porphobilinogen
became negative. In my opinion the patient was in an
acute attack of porphyria at the time of operation.
SUMMARY
A retrospec!ive study of 3~ 'patients with porphyria variegata
who were given 50 propamdld anaesthetics showed no adverse
reactions to the anaesthetic and in no patient was an attack of
acute porphyria precipitated. Furthermore, acute porphyria
a~er a propanidid anaesthetic has not been reported in Port
Elizabeth or elsewhere in South Africa.
'Yhen propanidid is used as an anaesthetic in porphyria
vanegata great care must be taken that no barbiturate sedalive
is given e.it~er pre-operatively or postoperatively.
Propamdld appears to be a safe intravenous anaesthetic for
patients who have inherited porphyria variegata.
. This study was made possible by the wholehearted coopera-
tIOn of the anaesthetists of Port Elizabeth, Drs E. C. Bloch,
J. D. Coxon, B. G. Francis, P. B. Hafner, M. J. Louw, W. E.
Owens, J. T. Russell, W. G. Staples, M. Towers and A. P. van
Wyk, and of Dr A. C. Anderson of Bloemfontein. Quantitative
analyses of stools were carried out by the SAIMR, Johannes-
burg, and my thanks are due to the Director of the Institute
Dr J. H. S. Gear of Johannesburg, and also to Dr W. C:
Harington, Director, Port Elizabeth, and their staff. In one case
the high stool porphyrin was confirmed by Prof. C. Rimington
of University College Hospital, London.
I sh~uld like to ~hank FBA Pharmaceuticals SA (Pty) Ltd
for the~r expert adVIce about the properties of propanidid and
for theIr support of this project; in particular my thanks are
due to their Medical Director, Dr H. Kraus.
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